Skip to main content
. 2002 Aug;54(2):107–114. doi: 10.1046/j.1365-2125.2002.01618.x

Figure 4.

Figure 4

The plasma cis-OH-perhexiline/perhexiline concentration ratio in 23 patients measured during the first 1–2 weeks of perhexiline treatment vs steady-state (P=0.005 initial vs steady-state value, Wilcoxon matched pairs test), showing putative poor (•), extensive (^) and ultra-rapid metabolizers (▴).